Insider · CIK 0001184160

FREIMAN PAUL E

Reports to the SEC for 4 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001184160

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-01-04	PENWEST PHARMACEUTICALS COStock Option Right-to-BuyA Award	Director	AAward	+12K sh	—	—	12,000
2009-09-03	PENWEST PHARMACEUTICALS COS Sale	Director	SSale	−3,466 sh	$2.35	−$8,145.1	29,255
2009-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	32,721
2008-12-17	NEUROBIOLOGICAL TECHNOLOGIES INC /CA/S Sale	Former officer and director	SSale	−400 sh	$0.21	−$84.08	14,986
2008-12-17	NEUROBIOLOGICAL TECHNOLOGIES INC /CA/S Sale	Former officer and director	SSale	−66 sh	$0.21	−$13.867	14,920
2008-12-16	NEUROBIOLOGICAL TECHNOLOGIES INC /CA/S Sale	Former officer and director	SSale	−970 sh	$0.56	−$543.2	15,416
2008-12-16	NEUROBIOLOGICAL TECHNOLOGIES INC /CA/S Sale	Former officer and director	SSale	−30 sh	$0.58	−$17.4	15,386
2008-12-10	NEUROBIOLOGICAL TECHNOLOGIES INC /CA/S Sale	Former officer and director	SSale	−1,000 sh	$0.61	−$610.1	16,386
2008-08-22	NEOPHARM INCOption to BuyA Award	Director	AAward	+50K sh	—	—	50,000
2008-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+139 sh	—	—	25,023
2008-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	31,023
2007-10-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+67 sh	—	—	24,636
2007-08-16	NEOPHARM INCA Award	Director	AAward	+50.8K sh	—	—	66,191
2007-07-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+60 sh	—	—	25,297
2007-06-13	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+112 sh	—	—	25,237
2007-05-29	PENWEST PHARMACEUTICALS COM Exercise/Conversion	Director	MExercise/Conversion	+1,999 sh	$7.51	+$15K	27,124
2007-05-29	PENWEST PHARMACEUTICALS COD Disposition to Issuer	Director	DDisposition to Issuer	−3,500 sh	$13.08	−$45.8K	25,125
2007-05-29	PENWEST PHARMACEUTICALS COStock Option (right-to-Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,999 sh	$7.51	−$15K	0
2007-05-29	PENWEST PHARMACEUTICALS COD Disposition to Issuer	Director	DDisposition to Issuer	−1,999 sh	$13.08	−$26.1K	25,125
2007-02-19	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+12K sh	—	—	31,125
2007-02-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+103 sh	—	—	18,911
2006-11-08	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+90 sh	—	—	12,762
2006-10-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+45 sh	—	—	12,672
2006-07-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+35 sh	—	—	12,538
2006-06-19	NEOPHARM INCA Award	Director	AAward	+8,090 sh	—	—	15,671
2006-06-07	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+81 sh	—	—	12,503
2006-05-01	PENWEST PHARMACEUTICALS COS Sale	Director	SSale	−10K sh	$19.90	−$199K	12,422
2006-01-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+39 sh	—	—	22,321
2006-01-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	22,282
2005-10-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+187 sh	—	—	16,189
2005-07-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+281 sh	—	—	15,909
2005-06-16	NEOPHARM INCA Award	Director	AAward	+5,081 sh	—	—	7,581
2005-06-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+122 sh	—	—	15,628
2005-04-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+420 sh	—	—	15,391
2005-02-16	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+145 sh	—	—	14,971
2005-01-03	PENWEST PHARMACEUTICALS COStock Options (Right-to-Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2005-01-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+441 sh	—	—	14,828
2004-11-30	NEOPHARM INCA Award	Director	AAward	+2,500 sh	—	—	2,500
2004-10-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+313 sh	—	—	14,252
2004-09-23	NEUROBIOLOGICAL TECHNOLOGIES INC /CA/Stock Option (right to buy)A Award	Former officer and director	AAward	+150K sh	—	—	150,000
2004-09-08	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)A Award	Director	AAward	+496 sh	$9.08	+$4,503.68	496
2004-04-14	PENWEST PHARMACEUTICALS COStock Option (Right-to_Buy)A Award	Director	AAward	+386 sh	$11.65	+$4,496.9	386
2004-01-02	PENWEST PHARMACEUTICALS COStock Option (Right-to-Buy)A Award	Director	AAward	+7,000 sh	$17.72	+$124K	7,000
2003-11-05	PENWEST PHARMACEUTICALS COStock Option (Right to Buy)A Award	Director	AAward	+369 sh	$12.18	+$4,494.42	369
2003-09-11	PENWEST PHARMACEUTICALS COStock Option (Right to Buy)A Award	Director	AAward	+287 sh	$15.68	+$4,500.16	287

Recent filings

Accepted (ET)
Jan 54
FREIMAN PAUL E0001209191-10-000987
SEC(opens sec.gov)
Sep 164
FREIMAN PAUL E0001209191-09-044540
SEC(opens sec.gov)
Feb 124
FREIMAN PAUL E0001181431-09-008526
SEC(opens sec.gov)
Jan 54
FREIMAN PAUL E0001209191-09-001125
SEC(opens sec.gov)
Aug 264
FREIMAN PAUL E0001104659-08-055182
SEC(opens sec.gov)
Jan 44
PENWEST PHARMACEUTICALS CO0001209191-08-001838
SEC(opens sec.gov)
Dec 204/A
NEOPHARM INC0001104659-07-090304
SEC(opens sec.gov)
Oct 24
PENWEST PHARMACEUTICALS CO0001209191-07-055905
SEC(opens sec.gov)
Jul 54
PENWEST PHARMACEUTICALS CO0001209191-07-041049
SEC(opens sec.gov)
Jun 144
PENWEST PHARMACEUTICALS CO0001209191-07-037002
SEC(opens sec.gov)
May 314
PENWEST PHARMACEUTICALS CO0001209191-07-034080
SEC(opens sec.gov)
Apr 244
PENWEST PHARMACEUTICALS CO0001209191-07-025148
SEC(opens sec.gov)

Companies

Address

2100 VALLEJO STREET

SAN FRANCISCO, CA, 94123